tiprankstipranks
Trending News
More News >
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market

Shield Therapeutics (STX) Cash flow

Compare
38 Followers

Shield Therapeutics Cash Flow

GB:STX's free cash flow for Q2 2025 was £-4.49M. For the 2025 fiscal year, GB:STX's free cash flow was decreased by £33.04M and operating cash flow was £-4.49M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
£ -7.01M£ -37.13M£ -18.25M£ -16.74M£ -1.40M
Investing Cash Flow
£ -1.89M£ -2.43M£ -1.70M£ -2.05M£ -20.00K
Financing Cash Flow
£ 4.21M£ 49.66M£ 7.71M£ 27.58M£ -47.00K
End Cash Position
£ 5.61M£ 13.95M£ 2.82M£ 12.12M£ 2.94M
Free Cash Flow
£ -7.03M£ -40.07M£ -20.14M£ -18.80M£ -1.42M
Currency in GBP

Shield Therapeutics Cash Flow